Abbott India (500488) Q2 26/27 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 26/27 earnings summary
5 Nov, 2026Executive summary
Q2 FY27 revenue from operations was ₹1,951.01 Cr and PAT was ₹453.45 Cr, both higher YoY; H1 revenue was ₹3,764.69 Cr and PAT was ₹881.97 Cr.
H1 operating cash flow reached ₹658.97 Cr, while cash and cash equivalents stood at ₹837.44 Cr at September 30, 2026.
Financial highlights
Q2 revenue from operations ₹1,951.01 Cr vs ₹1,757.15 Cr YoY; profit before tax ₹610.47 Cr vs ₹545.93 Cr.
Q2 PAT ₹453.45 Cr vs ₹415.27 Cr YoY; total comprehensive income ₹453.50 Cr vs ₹415.30 Cr.
H1 revenue from operations ₹3,764.69 Cr vs ₹3,495.50 Cr; PBT ₹1,182.68 Cr vs ₹1,039.06 Cr; PAT ₹881.97 Cr vs ₹781.13 Cr.
Segment performance
Operations are reported as one segment: Pharmaceuticals.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Abbott India
- Net profit surged 26.5% to ₹1,201 Crores on 9.4% revenue growth, with ₹410/share dividend proposed.500488
Q4 23/24 - Revenue and profit rose year-over-year, with a new Chairman appointed and clean auditor review.500488Q1 26/27
- Revenue and profit rose year-over-year, with higher dividends and an unmodified audit opinion.500488Q4 25/26
- Quarterly profit and revenue increased year-over-year, with new labour codes impacting costs.500488Q3 25/26
- Strong revenue and profit growth with robust cash flows and clean audit for Q2 FY26.500488Q2 25/26
- Q1 FY25 saw strong revenue and profit growth, with EPS up 13% year-over-year.500488Q1 24/25
- Strong revenue and profit growth with robust margins and clean audit for the latest quarter.500488Q3 24/25
- Quarterly profit and revenue increased year-over-year, with strong cash and no audit concerns.500488Q2 24/25
- Net profit rose to ₹1,414.44 crore with a higher dividend and strong cash flow for FY25.500488Q4 24/25